Psychiatry · Carmel, IN
NPI
1689659013
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
703 Pro-Med Ln
Carmel, IN, 46032
Phone (317) 843-9922
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
4,149 prescriptions
Company payments, 2025
$105K
From 21 companies
Medicare prescription drug claims, 2024
In 2024, the drug Christopher D Bojrab prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 249 prescriptions and refills. In total Christopher D Bojrab wrote 4,149 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Bupropion Xl Bupropion Hcl | 249 | 504 | 39 | $7,391 |
| Clonazepam Generic | 245 | 295 | 39 | $1,820 |
| Gabapentin Generic | 226 | 346 | 52 | $4,956 |
| Duloxetine Hcl Generic | 216 | 420 | 43 | $4,884 |
| Alprazolam Generic | 172 | 209 | 28 | $784 |
| Trazodone Hcl Generic | 151 | 285 | 37 | $3,471 |
| Lorazepam Generic | 117 | 133 | 22 | $1,395 |
| Lamotrigine Generic | 106 | 214 | 23 | $1,363 |
| Quetiapine Fumarate Generic | 102 | 174 | 21 | $2,061 |
| Mirtazapine Generic | 95 | 161 | 19 | $2,160 |
| Fluoxetine Hcl Generic | 95 | 185 | 23 | $1,243 |
| Armodafinil Generic | 87 | 106 | 16 | $9,702 |
| Vilazodone Hcl Generic | 83 | 111 | 12 | $11K |
| Zolpidem Tartrate Generic | 81 | 140 | 17 | $857 |
| Escitalopram Oxalate Generic | 79 | 142 | 16 | $855 |
Brand drugs: 429 claims; generic drugs: 3,720 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher D Bojrab $105K ($105K in general payments such as food, travel and fees) from 21 companies. The largest payer was Axsome Therapeutics, Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 53 | $27K |
| Abbvie Inc. ABBV | 59 | $26K |
| Vanda Pharmaceuticals Inc. VNDA | 52 | $18K |
| Eli Lilly and Company LLY | 6 | $12K |
| Teva Pharmaceuticals USA, Inc. TEVA | 16 | $8,968 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 22 | $5,790 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $3,446 |
| Noven Therapeutics, LLC | 2 | $1,050 |
| Neurocrine BioSciences, Inc. NBIX | 21 | $451 |
| Jazz Pharmaceuticals Inc. JAZZ | 7 | $413 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.